BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 30935692)

  • 1. Novel long non-coding RNA AV310809 promotes TGF-β1 induced epithelial-mesenchymal transition of human peritoneal mesothelial cells via activation of the Wnt2/β-catenin signaling pathway.
    Wei X; Huang H; Bao Y; Zhan X; Zhang L; Guo R; Hu N; Chen Q; Zhou J
    Biochem Biophys Res Commun; 2019 May; 513(1):119-126. PubMed ID: 30935692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy caused by oxidative stress promotes TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.
    Oh SH; Yook JM; Jung HY; Choi JY; Cho JH; Park SH; Kim CD; Kim YL; Lim JH
    Cell Death Dis; 2024 May; 15(5):365. PubMed ID: 38806451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
    Kinashi H; Ito Y; Mizuno M; Suzuki Y; Terabayashi T; Nagura F; Hattori R; Matsukawa Y; Mizuno T; Noda Y; Nishimura H; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
    J Am Soc Nephrol; 2013 Oct; 24(10):1627-42. PubMed ID: 23990681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the therapeutic effects and mechanisms of Roxadustat on peritoneal fibrosis Based on the TGF-β/Smad pathway.
    Wang L; Fan J; Yang T; Shen J; Wang L; Ge W
    Biochem Biophys Res Commun; 2024 Jan; 693():149387. PubMed ID: 38145606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor.
    Liu J; Feng Y; Li N; Shao QY; Zhang QY; Sun C; Xu PF; Jiang CM
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F273-F284. PubMed ID: 33427062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial-mesenchymal transition (MMT) of human peritoneal mesothelial cells.
    Kimura Y; Ohzawa H; Miyato H; Kaneko Y; Saito A; Takahashi K; Tojo M; Yamaguchi H; Kurashina K; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Sci Rep; 2022 Jan; 12(1):205. PubMed ID: 34997082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of chromatin accessibility and transcriptome landscapes in the induction of peritoneal fibrosis by high glucose.
    Song Q; Wang P; Wang H; Pan M; Li X; Yao Z; Wang W; Tang G; Zhou S
    J Transl Med; 2024 Mar; 22(1):243. PubMed ID: 38443979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.
    Zhong W; Fu J; Liao J; Ouyang S; Yin W; Liang Y; Liu K
    Int Urol Nephrol; 2024 Jun; 56(6):1987-1999. PubMed ID: 38097887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β1 induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer.
    Lv L; Liu FR; Na D; Xu HM; Wang ZN; Jiang CG
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32885819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA RPL29P2 promotes peritoneal fibrosis and impairs peritoneal transport function via miR-1184 in peritoneal dialysis.
    Li H; Zhang Y; Che M; Wang H; Li S; He P; Sun S; Xu G; Huang C; Liu X; Bai M; Zhou M; Su B; Zhang P; He L
    Int J Med Sci; 2024; 21(6):1049-1063. PubMed ID: 38774747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline.
    Fang CC; Huang JW; Shyu RS; Yen CJ; Shiao CH; Chiang CK; Hu RH; Tsai TJ
    PLoS One; 2012; 7(9):e44765. PubMed ID: 23028611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brahma-related gene 1 acts as a profibrotic mediator and targeting it by micheliolide ameliorates peritoneal fibrosis.
    Li S; Luo C; Chen S; Zhuang Y; Ji Y; Zeng Y; Zeng Y; He X; Xiao J; Wang H; Chen X; Long H; Peng F
    J Transl Med; 2023 Sep; 21(1):639. PubMed ID: 37726857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of culture supernatant of epithelial-like peritoneal mesothelial cells on peritoneal fibrosis.
    Takahashi K; Tsuji K; Nakanoh H; Fukushima K; Kitamura S; Wada J
    Perit Dial Int; 2024 May; 44(3):211-215. PubMed ID: 38017611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes.
    Szebeni B; Veres-Székely A; Pap D; Bokrossy P; Varga Z; Gaál A; Mihály J; Pállinger É; Takács IM; Pajtók C; Bernáth M; Reusz GS; Szabó AJ; Vannay Á
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRG1 accelerates mesothelial cell senescence and peritoneal fibrosis by inhibiting mitophagy through repression of OXR1.
    Li S; Zhuang Y; Ji Y; Chen X; He L; Chen S; Luo Y; Shen L; Xiao J; Wang H; Luo C; Peng F; Long H
    Free Radic Biol Med; 2024 Mar; 214():54-68. PubMed ID: 38311259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases.
    Tao M; Shi Y; Chen H; Li J; Wang Y; Ma X; Du L; Wang Y; Yang X; Hu Y; Zhou X; Zhong Q; Yan D; Qiu A; Zhuang S; Liu N
    Mol Biomed; 2024 Jan; 5(1):3. PubMed ID: 38172378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cellular senescence on the response of human peritoneal mesothelial cells to TGF-β.
    Kawka E; Herzog R; Ruciński M; Malińska A; Unterwurzacher M; Sacnun JM; Wagner A; Kowalska K; Jopek K; Kucz-Chrostowska A; Kratochwill K; Witowski J
    Sci Rep; 2024 Jun; 14(1):12744. PubMed ID: 38830931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in stem cell therapy for peritoneal fibrosis: from mechanisms to therapeutics.
    Huang W; Xia D; Bi W; Lai X; Yu B; Chen W
    Stem Cell Res Ther; 2023 Oct; 14(1):293. PubMed ID: 37817212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Peritoneal Sclerosis Rat Model Developed by Administration of Bleomycin and Lansoprazole.
    Kunitatsu K; Yamamoto Y; Nasu S; Taniji A; Kawashima S; Yamagishi N; Ito T; Inoue S; Kanai Y
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Sulodexide Prevents Peritoneal Fibrosis by Downregulating the Expression of TGF-
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9842747. PubMed ID: 38125084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.